Search results
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 7 hours agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 1 day agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Gateway - Quartz
Quartz· 1 hour agoJohnson & Johnson agreed this week to settle a multi-state case alleging it misled consumers about the safety of its talc-based powder products. Moderna said its experimental ...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 1 day agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Moderna Just Gave Investors Another Reason to Buy the Stock | The Motley Fool
The Motley Fool· 2 days agoModerna (MRNA -3.58%) is best known for its work in the coronavirus vaccine market. Let's look...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 1 day agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant...
Centers for Disease Control and Prevention· 8 hours agoVaccine Effectiveness among Household Contacts
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 6 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Moderna stock is lone omen of bird flu pandemic
Reuters· 1 day agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
